
|Articles|June 14, 2007
A new day in preventing meningococcal disease: Sizing up the available vaccines
The new conjugate vaccine MCV4 promises longer duration of immunity and, perhaps, greater clinical efficacy than the polysaccharide vaccine MPSV4. Questions remain about booster doses, vaccinating young children, and safety.
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Is shortened treatment for urinary tract infections a good idea?
2
Recurrent nausea and vomiting in an 18-year-old
3
Dupilumab's continued efficacy in pediatric EoE patients, with Joshua Wechsler, MD
4
Valeria Cohran, MD, discusses teduglutide response in children with SBS-IF
5












